TARDIVE DYSKINESIA (TD) TREATMENT
About the Disease
Tardive dyskinesia (TD) is a neurological movement disorder typically characterized by repetitive involuntary movements of the jaw, lips and tongue, and some individuals experience involuntary rapid jerking movements or slow, writhing movements in the arms and legs. The condition is a result of long-term use of certain types of neuroleptics, such as antipsychotics or major tranquilizers.
About our Patient Care
Our dedicated Care Team will work with the physician's office and insurance on a patient's behalf so that our patients have more time to focus on their treatment and quality of life. We are here to listen, provide
counseling on treatment, including side-effect management, and assist with sourcing third-party financial assistance.
As part of treatment, we provide:
Dedicated Care Team
We provide prescribers and patients with a dedicated care team for each of our disease state programs. This includes a primary pharmacy contact, clinical education, side-effects management, scheduled refill calls, and a direct phone, fax and email address.
Shipping and Coordination of Care
We provide free overnight delivery of medications and necessary medical supplies and manage the coordination of care between prescribers, sites of care, nurses and patients to ensure dispenses and drug delivery align with the date and location of service.
Financial Assistance
We successfully identify and assist enrolling patients into any and all manufacturer co-pay and foundation support programs in order to minimize a potential financial burden to patients given the high-cost of specialty medications.
24/7/365 Access to a Pharmacist
We provide prescribers and patients access to a pharmacist 24/7/365 to ensure patients are always cared for.
Supported Treatments
Click on the specialty drug name below to expand and see more information.
Austedo® XR (deutetrabenazine) Extended Release
Brand Name | Austedo XR (deutetrabenazine) Extended Release
Manufacturer | Teva
Route of Administration | Oral
Approved Indication | Tardive Dyskinesia
Self-Administration | Yes
Product Website | www.austedo.com
Austedo® (deutetrabenazine)
Brand Name | Austedo
Manufacturer | Teva
Route of Administration | Oral
Approved Indication | Treatment of Tardive Dyskinesia in Adults
Self-Administration | Yes
Product Website | www.austedo.com
Ingrezza® (valbenazine)
Brand Name | Ingrezza
Manufacturer | Neurocrine
Route of Administration | Oral
Approved Indication | Treatment for adults with tardive dyskinesia (TD)
Self-Administration | Yes
Product Website | www.ingrezza.com